AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...

This new option, known as FluMist, was released Friday and is the same vaccine formulation that has been available in doctors' offices for decades. Also in the news: covid, measles, and rabies.

The FDA approved AstraZeneca’s no-prescription FluMist vaccine in September 2024. Now with FluMist Home, people can have it ...

People who are pregnant, immunocompromised, and minors who take aspirin are advised not to take the vaccine, according to the company.Based on data from October 1, 2024, through May 17, 2025, the U.S.

Getting the flu is more than just uncomfortable—it can actually cause serious health complications (and even death) for older ...

AstraZeneca is making flu protection more convenient with the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine, the company announced Friday. On the market since 2003, ...

Starting Friday, Americans can order the nasal spray flu vaccine online and have it shipped directly to their home.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.